Sharp Health Plan
Zytiga (abiraterone)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 3 EA PER fill retail
  • Quantity Limit: 204 lancets per 30 day(s).
  • Parkinson's Disease:
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year
    Diagnosis Type(s): Unspecified
    Clinically documented acute, intermittent treatment of hypomobility "off" episodes: Yes
    Concomitant Use of Max Tolerable Dose of levodopa + 1 selegiline,pramipexole,entacapone,rasagiline: No
    Use as adjunct therapy: Yes
    Requires concomitant anti-emetic agent: No